2024-04-01 17:07:18
Atopic dermatitis not only affects the skin, but also has psychosocial impacts and associated comorbidities.
By: Valery Cardozo
April 01, 2024
Dr. Ángel Pagán, medical researcher, presented a historical and scientific vision of the dermatitis atopic disease, highlighting advances from the first records of Hippocrates to the most recent scientific developments.
On a morning full of purpose and collaboration, the Patient Support Alliance with Dermatitis Atopic held an educational event, bringing together a diversity of people committed to advancing the treatment of this dermatological condition. The event, held at the NUC University headquarters, was attended by students, teachers, health professionals and the general public.
Importance of understanding the dermatitis atopic as a multifaceted disease
Within the framework of the conference on dermatitis atopic disease, Dr. Ángel Pagán, a specialized doctor, addressed various historical and scientific aspects related to dermatitis atopic disease, as well as the most recent advances in its treatment and translational research in the field.
In his presentation, the specialist highlighted the importance of “understanding the dermatitis atopic disease not only as a skin disease, but as a multifaceted condition that affects various aspects of patients’ lives.
From physical symptoms such as persistent itching and skin lesions to psychosocial implications and associated comorbidities, dermatitis Atopic disease presents a comprehensive challenge that requires holistic therapeutic approaches. He also illustrated the complexity of the disease, from genetics to skin immunology.
Historical advances in the treatment of dermatitis atopic.
The researcher contextualized the condition from ancient times, mentioning figures such as Hippocrates and highlighting “the progress in understanding and treating the condition.” dermatitis atopic disease over the centuries.” He pointed out important milestones, such as the identification of genes involved in the epidermal barrier and the evolution of the terminology used to describe the disease.
Dr. Ángel Pagán’s presentation included a global vision of the prevalence of dermatitis atopic disease and the characteristic symptoms of the disease, such as chronic itching and skin lesions. Current therapeutic approaches, ranging from topical treatments to systemic therapies, were also discussed, highlighting the importance of improving patients’ quality of life.
Regarding the pathogenesis of the disease, the researcher delved into the immunological mechanisms involved, placing special emphasis on the role of TH2 cells and defects in the skin barrier. Additionally, he addressed associated comorbidities, such as anxiety and depression, and the importance of a comprehensive approach in managing the disease.
Translational research in dermatitis atopic: hope for new treatments
Dr. Pagán’s presentation also highlighted advances in translational research, which seeks to translate scientific findings into effective treatments for patients. Studies on gene expression, the microbiome were discussed cutaneous and response to treatment, as well as promising research into new targeted therapies.
In addition to addressing the clinical aspects of the disease, the researcher delved into the underlying mechanisms that contribute to its development and progression. From defects in the skin barrier to immune dysfunction, the complexity of the dermatitis atopic disease and the need to address it from multiple fronts.
In this sense, translational research plays a crucial role in seeking to translate scientific findings into tangible therapeutic advances for patients. From genetic studies to microbiome research cutaneousnew avenues are explored to better understand the disease and develop more effective and personalized treatments.
Dr. Ángel also emphasized “the importance of comprehensive care that takes into account the individual needs of each patient. This includes not only the treatment of skin symptoms, but also the care of associated comorbidities and the necessary psychosocial support to improve the quality of life of patients.
Biological medicines: a new hope for the control of dermatitis atopic
In terms of current and future treatments, the role of biological drugs was highlighted as a promising option for the control of inflammation in dermatitis atopic. These advances offer hope for those patients who do not respond adequately to conventional therapies and underline the importance of continued research in this field.
The specialist’s conference provided a comprehensive view of the dermatitis atopic, from its history to the most recent advances in its understanding and treatment. Its multidisciplinary approach and emphasis on translational research offer hope for improving the quality of life of patients with this debilitating disease.
1712008914
#Atopic #dermatitis #skin #disease #multifaceted #condition #Ángel #Pagán
